By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
India Times NowIndia Times NowIndia Times Now
Notification Show More
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Reading: Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price
Share
India Times NowIndia Times Now
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
Search
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Have an existing account? Sign In
Follow US

Home » Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price

BusinessStartup

Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price

India Times Now Desk
Last updated: January 29, 2026 8:18 am
India Times Now Desk
Published: January 29, 2026
Share
SHARE


The stock’s 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or overvalued, and below 30 is defined as oversold or undervalued.

Mumbai:

Shares of pharma company Sudarshan Pharma Industries Ltd are in focus as the company has reported a 16 per cent increase in net sales to Rs 168.01 crore and a 51 per cent surge in net profit to Rs 4.36 crore for the third quarter of fiscal year 2026. Following this, the stock started the trading session in green at Rs 20.25 against the previous close of Rs 19.30 on the BSE. However, the stock slipped amid profit booking and market volatility and touched the low of Rs 18.50, its 52-week low. The 52-week high of the stock is Rs 43.14, hit on January 29, 2025. Last seen, the stock was trading at Rs 18.53, and the market cap of the company stood at Rs 445.94 crore. 

The stock is trading lower than the 5-day, 20-day, 50-day, 100-day and 200-day moving averages. 

The stock’s 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or overvalued, and below 30 is defined as oversold or undervalued.

According to BSE Analytics, the stock has delivered a return of 150.41 per cent in two years, but has corrected 57.05 per cent in one year.

Company forms subsidiary

In the quarter ending December 31, 2025, the company approved the formation of a wholly-owned subsidiary – Sudarshan Pharma Poland Limited Liability Company. Also, the board of directors of the company gave its consent to raise funds of up to Rs 1,500 crore by issuing Foreign Currency Convertible Bonds (FCCB). The company has also submitted its application with the BSE to obtain in-principle approval for the issue of FCCB up to the amount of USD 3,50,00,000.

Share market today

Meanwhile, benchmark equity indices Sensex and Nifty declined in early trade on Thursday after a two-day rally as investors turned cautious ahead of the Union Budget presentation on Sunday.

The 30-share BSE Sensex dropped 343.67 points to 82,001.01 during initial trade. The 50-share NSE Nifty edged lower by 94.2 points to 25,248.55.

ALSO READ | Forgot money in your old bank account? Here’s how you can claim it back in few minutes

(This article is for informational purposes only and should not be construed as investment, financial, or other advice.)





Source link

Mark Zuckerberg promises to travel the entire United States in 2017
Tata Projects gets Rs 800 crore housing project contract from Experion Developers – Details
The internet has changed franchise business costs, but not the risks
Trump tariffs led businesses to take high interest rate loans
Which traffic challans are eligible for settlement at National Lok Adalat? Full guide for motorists
TAGGED:bseCheckfocusincreasesnsepharmaPricequarterly resultsresultsrevenuesharestockstock in focusSudarshan PharmaSudarshan Pharma share priceYoY
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
[mc4wp_form]
Popular News

33 nominations filed for bypolls in two Assembly segments in Jammu and Kashmir

India Times Now Desk
India Times Now Desk
October 20, 2025
Woman booked for gold theft attempts self-immolation near Human Rights Commission office
₹1 lakh crore investment push for aerospace, defence section in Andhra Pradesh
Delhi airport sees 15 flight diversions due to bad weather
AIMIM seeks entry into INDIA bloc ahead of Bihar Assembly election
- Advertisement -
Ad imageAd image
Global Coronavirus Cases

Confirmed

0

Death

0

More Information:Covid-19 Statistics
© INDIA TIMES NOW 2026 . All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?